From the Heiden Department of Cardiology, Bikur Cholim Hospital (S.B.);
the Departments of Vascular Surgery (Y.W.), Anatomy and Cell Biology (L.P.,
S.D.G.), and School of Pharmacy (G.G., I.F., L.R.), Hebrew
University–Hadassah Medical School; the Departments of Biological
Chemistry, Institute of Life Sciences (A.L., A.G.) and Organic Chemistry,
Institute of Chemistry (A.G.), Hebrew University; the Joseph Lunenfeld Cardiac
Surgery Research Center (A.S., G.L.), Jerusalem, Israel; and the Department of
Internal Medicine II (Cardiology), Ulm University Medical Center, Germany
(J.W., R.H.).
Correspondence to Shmuel Banai, MD, Department of Cardiology, Bikur Cholim Hospital, PO Box 492, Jerusalem 91004, Israel. E-mail banais{at}mail.netvision.net.il
Background—Signaling through protein
tyrosine kinases (PTKs) is a major contributor to the transmission of
mitogenic stimuli to the interior of the cell and nucleus.
The present study was designed to determine the effect of the
tyrphostin AG1295, a selective blocker of PDGF-receptor PTK, on the
growth of porcine and human smooth muscle cells (SMCs) in culture, on
the outgrowth kinetics of SMCs from porcine and human
arterial explants, and on neointimal formation
after balloon injury in pigs.
Methods and Results—SMCs for culture were obtained from porcine
abdominal aortas, human internal mammary arteries, and
endarterectomy tissue from a single human carotid
artery. Addition of AG1295 to SMCs before PDGF stimulation completely
inhibited PDGF-ß-receptor tyrosine phosphorylation
without affecting the level of PDGF-ß-receptor. AG1295 resulted in a
selective, reversible inhibition of SMC proliferation in culture (76%)
with only mild (13.5%) inhibition of endothelial cell
proliferation. The number of SMCs accumulating around explants of
porcine carotid arteries and human endarterectomy
specimens 12, 15, 19, 22, and 24 days after plating was reduced by 82%
to 92% in AG1295-treated compared with nontreated specimens, and
initiation of SMC outgrowth was markedly delayed. The numbers of cells
accumulated 10 days after initiation of outgrowth were significantly
lower in treated versus control explants. Local intravascular delivery
of AG1295-impregnated polylactic acid–based nanoparticles (130±25 nm)
to the site of balloon injury to porcine femoral arteries resulted in
significant reductions in intima/media area ratio and luminal
cross-sectional area narrowing by neointima compared with
contralateral control arteries to which empty nanoparticles were
applied (0.15±0.07 versus 0.09±0.03, P=.046 and
20±4% versus 10±4%, P=.0009, n=6 for both).
Conclusions—The tyrphostin AG1295, a selective blocker of
PDGF-receptor kinase, exerts a marked inhibitory effect on
the activation, migration, and proliferation of porcine and human SMCs
in vitro and an
© 1998 American Heart Association, Inc.
Basic Science Reports
PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine
50% inhibitory effect on
neointimal formation after balloon injury in porcine
femoral arteries when delivered via biodegradable nanoparticles.
Further studies appear to be warranted to evaluate the applicability of
this novel approach to the interventional setting.
Key Words: muscle, smooth • tyrosine kinase • tyrphostin • platelet-derived factors • restenosis
This article has been cited by other articles:
 |
|
 |
|
  J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Werth, D. Stuhlmann, B. Cat, H. Steinbrenner, L. Alili, H. Sies, and P. Brenneisen Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation Carcinogenesis, February 1, 2008; 29(2): 404 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jalvy, M.-A. Renault, L. L. S. Leen, I. Belloc, J. Bonnet, A.-P. Gadeau, and C. Desgranges Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration Cardiovasc Res, September 1, 2007; 75(4): 738 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Chen, F. Y. Lee, K. N. Bhalla, and J. Wu Potent Inhibition of Platelet-Derived Growth Factor-Induced Responses in Vascular Smooth Muscle Cells by BMS-354825 (Dasatinib) Mol. Pharmacol., May 1, 2006; 69(5): 1527 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. McKinnon, E. Gherardi, M. Reidy, and D. Bowyer Hepatocyte Growth Factor/Scatter Factor and MET Are Involved in Arterial Repair and Atherogenesis Am. J. Pathol., January 1, 2006; 168(1): 340 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zohlnhofer, J. Hausleiter, A. Kastrati, J. Mehilli, C. Goos, H. Schuhlen, J. Pache, G. Pogatsa-Murray, U. Heemann, J. Dirschinger, et al. A Randomized, Double-Blind, Placebo-Controlled Trial on Restenosis Prevention by the Receptor Tyrosine Kinase Inhibitor Imatinib J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1999 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Reinhardt, T. Mertens, U. Mayr-Beyrle, H. Frank, A. Luske, K. Schierling, and J. Waltenberger HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF {beta}-receptor Cardiovasc Res, July 1, 2005; 67(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Krepinsky, Y. Li, Y. Chang, L. Liu, F. Peng, D. Wu, D. Tang, J. Scholey, and A. J. Ingram Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1661 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2203 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Levitzki PDGF receptor kinase inhibitors for the treatment of restenosis Cardiovasc Res, February 15, 2005; 65(3): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kappert, K. G. Peters, F. D. Bohmer, and A. Ostman Tyrosine phosphatases in vessel wall signaling Cardiovasc Res, February 15, 2005; 65(3): 587 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Banai, S.D. Gertz, L. Gavish, M. Chorny, L. S. Perez, G. Lazarovichi, M. Ianculuvich, M. Hoffmann, M. Orlowski, G. Golomb, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries Cardiovasc Res, October 1, 2004; 64(1): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Dandre and G. K. Owens Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2042 - H2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schachner, Y. Zou, A. Oberhuber, A. Tzankov, T. Mairinger, G. Laufer, and J. O. Bonatti Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts Ann. Thorac. Surg., May 1, 2004; 77(5): 1580 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schachner, Y. Zou, A. Oberhuber, T. Mairinger, A. Tzankov, G. Laufer, H. Ott, and J. Bonatti Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 585 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Uzumcu, K. A. Dirks, and M. K. Skinner Inhibition of Platelet-Derived Growth Factor Actions in the Embryonic Testis Influences Normal Cord Development and Morphology Biol Reprod, March 1, 2002; 66(3): 745 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Fishbein, M. Chorny, S. Banai, A. Levitzki, H. D. Danenberg, J. Gao, X. Chen, E. Moerman, I. Gati, V. Goldwasser, et al. Formulation and Delivery Mode Affect Disposition and Activity of Tyrphostin-Loaded Nanoparticles in the Rat Carotid Model Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1434 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Heldin Signal Transduction: Multiple Pathways, Multiple Options for Therapy Stem Cells, July 1, 2001; 19(4): 295 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yamasaki, K. Miyoshi, N. Oda, M. Watanabe, H. Miyake, J. Chan, X. Wang, L. Sun, C. Tang, G. McMahon, et al. Weekly Dosing With the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor SU9518 Significantly Inhibits Arterial Stenosis Circ. Res., March 30, 2001; 88(6): 630 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, Y. Zhan, Y. Izumi, H. Yasumoto, M. Yano, and H. Iwao In Vivo Activation of Rat Aortic Platelet-Derived Growth Factor and Epidermal Growth Factor Receptors by Angiotensin II and Hypertension Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2539 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Leppanen, N. Janjic, M.-A. Carlsson, K. Pietras, M. Levin, C. Vargeese, L. S. Green, D. Bergqvist, A. Ostman, and C.-H. Heldin Intimal Hyperplasia Recurs After Removal of PDGF-AB and -BB Inhibition in the Rat Carotid Artery Injury Model Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20 (11): e89 - e95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Noiseux, C. H. Boucher, R. Cartier, and M. G. Sirois Bolus Endovascular PDGFR-{beta} Antisense Treatment Suppressed Intimal Hyperplasia in a Rat Carotid Injury Model Circulation, September 12, 2000; 102(11): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Peppel, A. Jacobson, X. Huang, J. P. Murray, M. Oppermann, and N. J. Freedman Overexpression of G Protein-Coupled Receptor Kinase-2 in Smooth Muscle Cells Attenuates Mitogenic Signaling via G Protein-Coupled and Platelet-Derived Growth Factor Receptors Circulation, August 15, 2000; 102(7): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Fishbein, J. Waltenberger, S. Banai, L. Rabinovich, M. Chorny, A. Levitzki, A. Gazit, R. Huber, U. Mayr, S. D. Gertz, et al. Local Delivery of Platelet-Derived Growth Factor Receptor-Specific Tyrphostin Inhibits Neointimal Formation in Rats Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 667 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iwasaki, S. Eguchi, H. Ueno, F. Marumo, and Y. Hirata Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H521 - H529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waltenberger, A. Uecker, J. Kroll, H. Frank, U. Mayr, J. D. Bjorge, D. Fujita, A. Gazit, V. Hombach, A. Levitzki, et al. A Dual Inhibitor of Platelet-Derived Growth Factor {beta}-Receptor and Src Kinase Activity Potently Interferes With Motogenic and Mitogenic Responses to PDGF in Vascular Smooth Muscle Cells : A Novel Candidate for Prevention of Vascular Remodeling Circ. Res., July 9, 1999; 85(1): 12 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pethig, B. Heublein, R. R. Meliss, and A. Haverich Volumetric remodeling of the proximal left coronary artery: Early versus late after heart transplantation J. Am. Coll. Cardiol., July 1, 1999; 34(1): 197 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Rice, C. R. Moomaw, D. L. Morgan, and J. C. Bonner Specific Inhibitors of Platelet-Derived Growth Factor or Epidermal Growth Factor Receptor Tyrosine Kinase Reduce Pulmonary Fibrosis in Rats Am. J. Pathol., July 1, 1999; 155(1): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Hart, L. W. Kraiss, S. Vergel, D. Gilbertson, R. Kenagy, T. Kirkman, D. L. Crandall, S. Tickle, H. Finney, G. Yarranton, et al. PDGFß Receptor Blockade Inhibits Intimal Hyperplasia in the Baboon Circulation, February 2, 1999; 99(4): 564 - 569. [Abstract] [Full Text] [PDF]
|
|